Dow Up 0.51% Nasdaq Up 0.24%

More On ENMD

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

EntreMed Inc. (ENMD)

-NasdaqCM
1.74 0.00(0.00%) Jun 13
Prev Close:1.74
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:1.00
Beta:2.31
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:1.45 - 2.34
Volume:0
Avg Vol (3m):20,385
Market Cap:N/A
P/E (ttm):N/A
EPS (ttm):-0.22
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ENMD 0.00%N/A
PGLAUp 16.67%11.61M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

EntreMed, Inc., a clinical-stage pharmaceutical company, develops therapeutics to treat cancer and other diseases primarily in the United States and China. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback